Skip to main content
. 2021 Dec 29;82:105903. doi: 10.1016/j.ultsonch.2021.105903

Fig. 3.

Fig. 3

Effect of Cis, US, US + AuNCs, US + Cis, and US + AuNCs + Cis treatments on cell viability in A2780/A2780cis ovarian cancer cell lines. A2780 (a) and A2780cis (b) ovarian cancer cells were treated separately with Cis, US, US + AuNCs, US + Cis, and US + AuNCs + Cis combination therapy, and cell viability was analyzed with resazurin 2 days after treatments. (*p-values < 0.05).